Is Baxter International an Underrated Healthcare Investment Play?

Company Overview - Baxter International manufactures essential medical products such as surgical sealants and hospital beds, which are crucial for the healthcare industry [2] - The aging baby boomer generation is expected to increase demand for healthcare, thereby boosting demand for Baxter's products [2] Recent Performance - Baxter has faced inconsistent revenue and has reported losses, leading to a significant stock decline of approximately 75% over the past five years [5] - The company recently cut its dividend from $0.17 per share per quarter to a token penny, reflecting its current financial struggles [1][5] Investment Considerations - Despite recent challenges, Baxter's products are deemed necessary, suggesting the company may navigate through its current difficulties [5] - The company maintains a manageable level of debt, covering its interest costs two times over, which provides some financial stability [5] - The stock's valuation appears attractive, with price-to-sales and price-to-book ratios below their five-year averages, indicating it may be undervalued [6] Future Outlook - There is potential for turnaround investors to find value in Baxter, as the demand for its products is expected to grow in the long term [7] - However, recovery may take time and could be uneven, particularly given the recent dividend cut which may deter income-focused investors [7]